Drawing for NOVOSKIN

USPTO serial 98687566

NOVOSKIN

Reviewed by CopyMark Law Group

Reg. 8340502Status 700Registered
Filing date
Status date
Registration date
Jul 14, 2026
Examiner
DRUHAN, CONNOR M
Law office
INTENT TO USE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NOVOSKIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel P. Mullarkey

Daniel P. Mullarkey Polsinelli PCPO BOX 140310Kansas City, MO 64114-0310United States

Goods and services

ClassDescriptionStatusFirst use
005Biological tissue grafts, namely, bioresorbable grafts for use in tissue regeneration; biological skin bioresorbable grafts for use in surgery; medical plasters; medical and wound dressings; skin grafts, plasters and dressings all being for use in burn and wound care; plasters and dressings all being for use in chronic or acute wound care; biological bioresorbable tissue grafts and bioresorbable implants comprised of living tissue for use in soft tissue repairACTIVE—
010Surgical tissue reconstruction grafts being made from artificial materials; bioresorbable surgical tissue reconstruction grafts being made from artificial materials; surgical tissue reconstruction grafts being made from artificial materials which are porous; surgical tissue reconstruction grafts being made from artificial materials in the form of foam, sheet or mesh; surgical grafts made of artificial materials for use in soft tissue reinforcement and augmentation; artificial skin for surgical purposes; artificial skin replacing membranes for medical purposes; Implants consisting of artificial materials in the nature of bioresorbable polymer scaffold products, namely, grafts, implants, foam, sheet, mesh, and artificial skin, for use in burn and wound care; Implants consisting of artificial materials in the nature of bioresorbable polymer scaffold products, namely, grafts, implants, foam, sheet, mesh, and artificial skin, for use in chronic or acute wound care; surgical tissue grafts and reconstruction implants made from artificial materials for use in soft tissue repair; implantable scaffolds, surgical tissue grafts and reconstruction implants made from artificial materials in the form of foam, sheet or mesh for use in repair and treatment of chronic or acute wounds; surgical mesh made of artificial materials; surgical foams being implants made of artificial materials for use in tissue reconstruction in tissue reconstruction; surgical slings being tissue implants made of artificial materials; implantable scaffolds, surgical tissue grafts and reconstruction implants made from artificial materials for use in the repair and treatment of internal and external wounds; surgical apparatus in the nature of implantable biodegradable porous devices made of artificial material for use in the repair and treatment of internal and external wounds; implantable scaffolds, surgical grafts and implants made from artificial materials for use in soft tissue repair, reinforcement and augmentation; surgical implants and grafts made of artificial materials for dermal repair and regeneration; surgical reconstruction implants and skin grafts made of artificial materials for treatment and repair of burns; surgical implants and skin grafts made of artificial materials for wound repair and closureACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 14, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 14, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 22, 2026DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jan 29, 2026IUCNNOTICE OF ALLOWANCE CANCELLED—
Jan 29, 2026D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Jan 13, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 18, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 18, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 12, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 15, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 15, 2025ALIEASSIGNED TO LIE—
Oct 6, 2025ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 29, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 29, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Sep 29, 2025CNSLSUSPENSION LETTER WRITTEN—
Sep 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 3, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 30, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 30, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 3, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2025DOCKASSIGNED TO EXAMINER—
Jan 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 7, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance